We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleBCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome.AuthorsVisentin, Andrea; Imbergamo, Silvia; Scomazzon, Edoardo; Pravato, Stefano; Frezzato, Federica; Bonaldi, Laura; Pizzi, Marco; Vio, Stefania; Gregianin, Michele; Burei, Marta; Facco, Monica; Semenzato, Gianpietro; Piazza, Francesco; Trentin, LivioPublicationBritish journal of haematology, 2019, Vol 185, Issue 1, p193ISSN1365-2141Publication typeResearchDOI10.1111/bjh.15440